We are Sorry, This Page doesn't Exist

Caladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q2 2019 Results - Earnings Call Transcript.....»»

Federal agencies and private investors largely continue to shy away from funding potential treatments of the autoimmune condition celiac disease......»»

A monoclonal antibody called teplizumab has been shown to delay the onset of type 1 diabetes for as long as two years. About 1.25 million Americans suffer from the disease, a form of diabetes in........»»

Researchers at Massachusetts General Hospital have been studying a generic drug that's shown potential to cure type 1 diabetes in adults. Now, researchers want to test the same drug in children with the disease. Dr. Denise Faustman, director of the Mas.....»»

Decades of research has shown that chronic short sleep is associated with increased risk of clogged arteries, heart disease, and early mortality......»»

Caladrius Biosciences, Inc."s (CLBS) CEO David Mazzo on Q1 2019 Earnings Conference Call Transcript.....»»

Decades of research has shown that chronic short sleep is associated with increased risk of clogged arteries, heart disease, and early mortality......»»

Caladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q4 2018 Earnings Conference Call Transcript.....»»

23andMe is adding a report to its health and ancestry DNA test for type 2 diabetes. That's a huge market opportunity as 1 in 3 people are at risk for developing the disease. More than 30 million people in the U.S. alone have diabetes......»»

Shutterstock/ nd3000  Having lots of fat in the abdominal area is strongly linked to diseases like type 2 diabetes and heart disease. Excess sugar and carb consumptio.....»»

Caladrius Biosciences Inc (NASDAQ: CLBS) shares were trading sharply higher for a second straight session Wednesday after the FDA granted a special status for its CD34+ cell therapy. read more.....»»

Caladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q2 2018 Results - Earnings Call Transcript.....»»

As of late, it has definitely been a great time to be an investor in Cala.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Caladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q3 2018 Earnings Conference Call Transcript.....»»

Caladrius Biosciences (CLBS) Investor Presentation - Slideshow.....»»

As part of three now-canceled offshore wind projects, the Capital Region had been line for funding to construct manufacturing facilities......»»

read more.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»